Stewart Appelrouth, Director at AIM ImmunoTech Inc. (AIM), bought 10,638 shares at $2.35 ($25K) on 2021-02-25, disclosed to the SEC on 2021-02-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| AIM | BUY | 2024-03-18 | $30K | — | Filing → |
| AIM | BUY | 2023-01-04 | $25K | — | Filing → |
| HEB | BUY | 2019-06-25 | $39K | — | Filing → |